๐Ÿ•ต๏ธ Citius Pharmaceuticals, Inc. ($CTXR)

SEC insider & ownership activity, last 12 months ยท CIK 1506251 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Feb 9, 2026.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
CVI Investments, Inc. 9.9% 13GFeb 17, 2026 filing โ†—
Heights Capital Management, Inc. 9.9% 13GFeb 17, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Other events (8.01)Jun 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 1, 2026 filing โ†—
Earnings (2.02)May 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 15, 2026 filing โ†—
Material agreement (1.01)May 4, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 4, 2026 filing โ†—
Unregistered equity sale (3.02)Apr 23, 2026 filing โ†—
Other events (8.01)Apr 23, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 23, 2026 filing โ†—
Material agreement (1.01)Apr 23, 2026 filing โ†—
Other events (8.01)Apr 23, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 23, 2026 filing โ†—
Shareholder vote (5.07)Apr 6, 2026 filing โ†—
Other events (8.01)Mar 31, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 31, 2026 filing โ†—
Other events (8.01)Mar 10, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 10, 2026 filing โ†—
Other events (8.01)Mar 4, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 4, 2026 filing โ†—
Earnings (2.02)Feb 9, 2026 filing โ†—
Delisting notice (3.01)Feb 9, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 9, 2026 filing โ†—
Earnings (2.02)Dec 23, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 23, 2025 filing โ†—
Reg FD disclosure (7.01)Dec 1, 2025 filing โ†—
Other events (8.01)Dec 1, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Dec 1, 2025 filing โ†—
Reg FD disclosure (7.01)Oct 23, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 23, 2025 filing โ†—
Material agreement (1.01)Oct 20, 2025 filing โ†—